Literature DB >> 1344779

Juvenile myoclonic epilepsy of Janz: clinical observations in 60 patients.

M P Canevini1, R Mai, C Di Marco, C Bertin, L Minotti, V Pontrelli, A Saltarelli, R Canger.   

Abstract

We studied 60 patients with juvenile myoclonic epilepsy (JME). There was a high positive family history for epilepsy (33.3%). Age at onset of epilepsy ranged from 4 to 18 years with an average of 13.9 years. 88.3% of patients were seizure-free. The most effective drug was valproate. In eight patients drug withdrawal was attempted but all patients relapsed during a follow-up period of 1 year. Video-EEG studies were performed in eight newly diagnosed patients; myoclonic jerks were recorded in five patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1344779     DOI: 10.1016/1059-1311(92)90039-4

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

1.  Treatment options in juvenile myoclonic epilepsy.

Authors:  Laura Mantoan; Matthew Walker
Journal:  Curr Treat Options Neurol       Date:  2011-08       Impact factor: 3.598

Review 2.  Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.

Authors:  Timothy E Welty
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

3.  Interictal mood and personality disorders in temporal lobe epilepsy and juvenile myoclonic epilepsy.

Authors:  G I Perini; C Tosin; C Carraro; G Bernasconi; M P Canevini; R Canger; A Pellegrini; G Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

4.  Seizure control in mono- and combination therapy in a cohort of patients with Idiopathic Generalized Epilepsy.

Authors:  Leonardo Zumerkorn Pipek; Henrique Zumerkorn Pipek; Luiz Henrique Martins Castro
Journal:  Sci Rep       Date:  2022-07-19       Impact factor: 4.996

5.  Headache in juvenile myoclonic epilepsy.

Authors:  Christoph J Schankin; Jan Rémi; Ira Klaus; Petra Sostak; Veronika M Reinisch; Soheyl Noachtar; Andreas Straube
Journal:  J Headache Pain       Date:  2011-03-25       Impact factor: 7.277

6.  Juvenile myoclonic epilepsy mimic associated with CHD2 gene mutation.

Authors:  Neeraj Singh; Anthony Ritaccio
Journal:  Epilepsy Behav Rep       Date:  2020-01-07

7.  Refractory juvenile myoclonic epilepsy: a meta-analysis of prevalence and risk factors.

Authors:  R Stevelink; B P C Koeleman; J W Sander; F E Jansen; K P J Braun
Journal:  Eur J Neurol       Date:  2018-10-07       Impact factor: 6.089

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.